Skip to content

Prospective observational study on child development born to mother with antiepileptic drugs

Prospective observational study on child development born to mother with antiepileptic drugs - Prospective observational study on child development born to mother with antiepileptic drugs(JES-AEDs-CH)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000038908
Enrollment
400
Registered
2020-04-01
Start date
2020-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Interventions

None listed

Sponsors

National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Child with parental consent born to mother with epilepsy (2) The mother must be participating in JES-AEDs-PG.

Exclusion criteria

Exclusion criteria: (1) Those judged as inappropriate for participation in this study by the principal investigator/sub-investigators

Design outcomes

Primary

MeasureTime frame
Cognitive development of children exposed to AEDs during fetus

Secondary

MeasureTime frame
-Safety of breastfeeding while taking antiepileptic drugs -Influence of seizures during pregnancy upon cognitive development of the child -Intake of folic acid and its effect on cognitive development -Relation between antiepileptic drug dose (and its serum concentration) and cognitive development of the child -Correlation of cognitive status of the child with that of mother

Countries

Japan

Contacts

Public ContactHideyuki Ohtani

National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders Division of clinical Research

h-ohtani@shizuokamind.org054-245-5446

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026